N-able price target lowered to $8.50 from $13.50 at BMO Capital

BMO Capital lowered the firm’s price target on N-able (NABL) to $8.50 from $13.50 and keeps a Market Perform rating on the shares. The company reported a reasonable Q4, but the management’s FY25 revenue and adjusted EBITDA margin guide, inclusive of Adlumin, is weaker than expected, the analyst tells investors in a research note. N-able’s implied organic growth for next year is disappointing, partially due to ongoing annual contract initiative headwinds, though the firm is positive on Adlumin and the company’s opportunity in the security market more broadly, BMO added.